PRIMA launches commercially in Europe with a CE mark
Science begins selling PRIMA in Europe for geographic atrophy caused by macular degeneration.
Brain-computer interfacesscience.xyz
StartupUSfounded 20211 field
| Technology | ||
|---|---|---|
| Brain-computer interfacesSells the PRIMA subretinal implant for vision loss and develops biohybrid neural interfaces. | Sells the PRIMA subretinal implant for vision loss and develops biohybrid neural interfaces. | science.xyz |
Science begins selling PRIMA in Europe for geographic atrophy caused by macular degeneration.
The subretinal implant restored functional central vision in patients with geographic atrophy.
Science reports preliminary positive results for vision restoration in the PRIMAvera pivotal trial.
Science takes over the PRIMA retinal prosthesis and its ongoing clinical trials from Pixium Vision.